Vitamin D: extraskeletal health.

[1]  P. Toth.  1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus , 2010 .

[2]  M. Holick,et al.  Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. , 2009, Archives of internal medicine.

[3]  T. Marshall,et al.  Vitamin D: the alternative hypothesis. , 2009, Autoimmunity reviews.

[4]  Douglass Bibuld.  Health Disparities and Vitamin D , 2009 .

[5]  C. Camargo,et al.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.

[6]  D. Bikle.  Nonclassic actions of vitamin D. , 2009, The Journal of clinical endocrinology and metabolism.

[7]  J. O’Keefe,et al.  Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? , 2008, Journal of the American College of Cardiology.

[8]  C. Wagner,et al.  Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents , 2008, Pediatrics.

[9]  M. Holick,et al.  Plasma 25-Hydroxyvitamin D Levels in Young Children Undergoing Placement of Tympanostomy Tubes , 2008, The Annals of otology, rhinology, and laryngology.

[10]  M. Holick.  Vitamin D and sunlight: strategies for cancer prevention and other health benefits. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[11]  S. Mohr,et al.  The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide , 2008, Diabetologia.

[12]  John H. White.  Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity , 2008, Infection and Immunity.

[13]  M. Holick,et al.  Vitamin D deficiency: a worldwide problem with health consequences. , 2008, The American journal of clinical nutrition.

[14]  M. Holick,et al.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.

[15]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[16]  J. Moan,et al.  Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure , 2008, Proceedings of the National Academy of Sciences.

[17]  C. Daniel,et al.  Immune Modulatory Treatment of Trinitrobenzene Sulfonic Acid Colitis with Calcitriol Is Associated with a Change of a T Helper (Th) 1/Th17 to a Th2 and Regulatory T Cell Profile , 2008, Journal of Pharmacology and Experimental Therapeutics.

[18]  M. Holick,et al.  Vitamin D and Skin Physiology: A D‐Lightful Story , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[20]  Stephen B. Thomas,et al.  SOLAR ultraviolet radiation and vitamin D: a historical perspective. , 2007, American journal of public health.

[21]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[22]  Glenville Jones.  PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Expanding Role for Vitamin D in Chronic Kidney Disease: Importance of Blood 25‐OH‐D Levels and Extra‐Renal 1α‐Hydroxylase in the Classical and Nonclassical Actions of 1α,25‐Dihydroxyvitamin D3 , 2007 .

[23]  R. Recker,et al.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.

[24]  J. Knight,et al.  Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[25]  E. Giovannucci,et al.  Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. , 2007, American journal of preventive medicine.

[26]  E. Giovannucci,et al.  Vitamin D and prevention of breast cancer: Pooled analysis , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  A. Litonjua,et al.  Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. , 2007, The American journal of clinical nutrition.

[28]  H. Pols,et al.  Vitamin D , 1928, Calcified Tissue International.

[29]  C. Ryan,et al.  Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer , 2007, Cancer Chemotherapy and Pharmacology.

[30]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[31]  W. Willett,et al.  Cancer Incidence and Mortality and Vitamin D in Black and White Male Health Professionals , 2006, Cancer Epidemiology Biomarkers & Prevention.

[32]  S. Madronich,et al.  Epidemic influenza and vitamin D , 2006, Epidemiology and Infection.

[33]  M. Holick.  Resurrection of vitamin D deficiency and rickets. , 2006, The Journal of clinical investigation.

[34]  M. Holick,et al.  Vitamin D and cancer. , 2006, Anticancer research.

[35]  U. Fischer,et al.  Expression analysis of CYP27B1 in tumor biopsies and cell cultures. , 2006, Anticancer research.

[36]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[37]  E. Giovannucci.  Calcium plus vitamin D and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[38]  Yan Liu,et al.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.

[39]  Maureen L. Coleman,et al.  Genomic Islands and the Ecology and Evolution of Prochlorococcus , 2006, Science.

[40]  W. Grant.  Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. , 2006, Journal of the National Medical Association.

[41]  J. Manson,et al.  Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.

[42]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[43]  R. Vieth,et al.  Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. , 2006, The Journal of clinical endocrinology and metabolism.

[44]  S. Seton.  Collected Writings: Volume 3a , 2006 .

[45]  R. Scragg,et al.  Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. , 2005, Chest.

[46]  M. Holick,et al.  Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[47]  W. Willett,et al.  Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[48]  S. Nagpal,et al.  Noncalcemic actions of vitamin D receptor ligands. , 2005, Endocrine reviews.

[49]  J. Aloia,et al.  A randomized controlled trial of vitamin D3 supplementation in African American women. , 2005, Archives of internal medicine.

[50]  W. Grant,et al.  Benefits and requirements of vitamin D for optimal health: a review. , 2005, Alternative medicine review : a journal of clinical therapeutic.

[51]  R. Vieth,et al.  Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients With PSA Relapse After Definitive Therapy , 2005, Nutrition and cancer.

[52]  Hirofumi Tanaka,et al.  I a,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60) The presence of a cytosol receptor and induction of differentiation , 2005 .

[53]  Yan Zhu,et al.  Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. , 2004, The American journal of clinical nutrition.

[54]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. , 2004, Diabetes care.

[55]  A. Bernad,et al.  The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer , 2004, Nature Medicine.

[56]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[57]  L. Adorini,et al.  Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. , 2004, Seminars in immunology.

[58]  W. Willett,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[59]  M. Hakama,et al.  Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) , 2000, Cancer Causes & Control.

[60]  J. Cerhan,et al.  Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. , 2004, Arthritis and rheumatism.

[61]  M. Holick,et al.  Vitamin D and prostate cancer prevention and treatment , 2003, Trends in Endocrinology & Metabolism.

[62]  M. Holick,et al.  Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. , 2003, The American journal of clinical nutrition.

[63]  P. Dhawan,et al.  New insights into the mechanisms of vitamin D action , 2003, Journal of cellular biochemistry.

[64]  M. Holick.  Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.

[65]  G. Cook,et al.  Primer on the metabolic bone diseases and disorders of mineral metabolism , 2003 .

[66]  M. Holick.  VITAMIN D: A MILLENNIUM PERSPECTIVE , 2003 .

[67]  G. Tenderich,et al.  Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.

[68]  M. Holick,et al.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.

[69]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[70]  M. Holick.  Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health , 2002 .

[71]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[72]  R. Strange,et al.  Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer , 2001, The Lancet.

[73]  D. Feldman,et al.  The role of vitamin D in prostate cancer , 2001, Steroids.

[74]  E. Bajna,et al.  25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis , 2001, Steroids.

[75]  J. Flanagan,et al.  25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. , 2001, Lancet.

[76]  M. Cantorna,et al.  1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.

[77]  R. Vieth,et al.  Vitamin D and seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2000, Annals of neurology.

[78]  D. Feldman,et al.  Editorial/Mini-Review: Vitamin D and Prostate Cancer. , 2000, Endocrinology.

[79]  M. Hernán,et al.  Geographic variation of MS incidence in two prospective studies of US women , 1999, Neurology.

[80]  Arya M. Sharma,et al.  Ultraviolet B and blood pressure , 1998, The Lancet.

[81]  T. Stamey,et al.  Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol) , 1998, The Journal of urology.

[82]  T. Chen,et al.  Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[83]  C. Bell,et al.  Ultraviolet light may contribute to geographic and racial blood pressure differences. , 1998, Hypertension.

[84]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[85]  M. Holick,et al.  Efficacy and safety of topical calcitriol (1,25‐dihydroxyvitamin D3) for the treatment of psoriasis , 1996, The British journal of dermatology.

[86]  R. Bouillon,et al.  Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.

[87]  M. F. Stewart,et al.  Constitutive synthesis of 1,25-dihydroxyvitamin D3 by a human small cell lung cancer cell line. , 1994, The Journal of clinical endocrinology and metabolism.

[88]  G. Schwartz,et al.  Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation , 1992, Cancer.

[89]  C. Garland,et al.  Can colon cancer incidence and death rates be reduced with calcium and vitamin D? , 1991, The American journal of clinical nutrition.

[90]  K. Kragballe.  Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903) , 1989, Archives of dermatology.

[91]  H. Koeffler,et al.  1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. , 1985, Cancer treatment reports.

[92]  J. Adams,et al.  Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. , 1985, The Journal of clinical endocrinology and metabolism.

[93]  E. Hendler,et al.  Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. , 1984, The New England journal of medicine.

[94]  E. Abe,et al.  1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). , 1982, The Biochemical journal.

[95]  D. Feldman,et al.  1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. , 1981, Endocrinology.

[96]  H. DeLuca,et al.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. , 1979, Science.

[97]  F. Apperly.  The Relation of Solar Radiation to Cancer Mortality in North America , 1941 .

[98]  C. Winslow,et al.  The Mortality from Cancer Throughout the World , 1916, The Indian Medical Gazette.